Display options
Cite
Grant WB. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality. Dermatoendocrinol. 2009;1(1):17-24doi: 10.4161/derm.1.1.7388.
Grant, W. B. (2009). How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality. Dermato-endocrinology, 1(1), 17-24. https://doi.org/10.4161/derm.1.1.7388
Grant, William B. "How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality." Dermato-endocrinology vol. 1,1 (2009): 17-24. doi: https://doi.org/10.4161/derm.1.1.7388
Grant WB. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality. Dermatoendocrinol. 2009 Jan;1(1):17-24. doi: 10.4161/derm.1.1.7388. PMID: 20046584; PMCID: PMC2715209.
Copy Download .nbib Format: NLM
Share it on

Dermatoendocrinol. 2009 Jan;1(1):17-24. doi: 10.4161/derm.1.1.7388.

How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality.

Dermato-endocrinology

William B Grant

Affiliations

  1. Sunlight Nutrition and Health Research Center (SUNARC); San Francisco, California USA.

PMID: 20046584 PMCID: PMC2715209 DOI: 10.4161/derm.1.1.7388

Abstract

The ultraviolet-B (UVB)-vitamin D-cancer hypothesis was proposed in 1980. Since then, several ecological and observational studies have examined the hypothesis, in addition to one good randomized, controlled trial. Also, the mechanisms whereby vitamin D reduces the risk of cancer have been elucidated. This report aims to examine the evidence to date with respect to the criteria for causality in a biological system first proposed by Robert Koch and later systematized by A. Bradford Hill. The criteria of most relevance are strength of association, consistency, biological gradient, plausibility/mechanisms and experimental verification. Results for several cancers generally satisfy these criteria. Results for breast and colorectal cancer satisfy the criteria best, but there is also good evidence that other cancers do as well, including bladder, esophageal, gallbladder, gastric, ovarian, rectal, renal and uterine corpus cancer, as well as Hodgkin's and non-Hodgkin's lymphoma. Several cancers have mixed findings with respect to UVB and/or vitamin D, including pancreatic and prostate cancer and melanoma. Even for these, the benefit of vitamin D seems reasonably strong. Although ecological and observational studies are not generally regarded as able to provide convincing evidence of causality, the fact that humanity has always existed with vitamin D from solar UVB irradiance means that there is a wealth of evidence to be harvested using the ecological and observational approaches. Nonetheless, additional randomized, controlled trials are warranted to further examine the link between vitamin D and cancer incidence, survival and mortality.

Keywords: association; breast cancer; colon cancer; dose-response; ecologic; mechanisms; observational; supplements; viral infections

References

  1. Am J Clin Nutr. 1999 Jun;69(6):1309S-1314S - PubMed
  2. Am J Prev Med. 2007 Mar;32(3):210-6 - PubMed
  3. J Clin Oncol. 2008 Jun 20;26(18):2984-91 - PubMed
  4. Nat Clin Pract Endocrinol Metab. 2008 Feb;4(2):80-90 - PubMed
  5. Int J Epidemiol. 1994 Dec;23(6):1133-6 - PubMed
  6. Cancer Causes Control. 2004 Mar;15(2):149-58 - PubMed
  7. Nat Rev Cancer. 2003 Aug;3(8):601-14 - PubMed
  8. Am J Pathol. 2008 Nov;173(5):1589-90 - PubMed
  9. Eur J Cancer. 2008 Jan;44(1):12-5 - PubMed
  10. Anticancer Res. 2006 Jul-Aug;26(4A):2687-99 - PubMed
  11. Recent Results Cancer Res. 2003;164:371-7 - PubMed
  12. N Engl J Med. 2006 Feb 16;354(7):684-96 - PubMed
  13. J Natl Cancer Inst. 2005 Feb 2;97(3):195-9 - PubMed
  14. BMJ. 2008 Jun 14;336(7657):1318-9 - PubMed
  15. Int J Cancer. 2007 Mar 1;120(5):1123-8 - PubMed
  16. Am J Prev Med. 2006 Dec;31(6):512-4 - PubMed
  17. Lung Cancer. 2004 Aug;45 Suppl 2:S3-9 - PubMed
  18. Prev Med. 1990 Nov;19(6):614-22 - PubMed
  19. Hematol Oncol Clin North Am. 2000 Aug;14(4):797-807, viii - PubMed
  20. Br J Cancer. 2007 May 21;96(10):1554-9 - PubMed
  21. Am J Pathol. 2008 Jun;172(6):1717-28 - PubMed
  22. PLoS Med. 2007 Mar;4(3):e103 - PubMed
  23. Int J Cancer. 2006 Dec 1;119(11):2705-9 - PubMed
  24. J Natl Cancer Inst. 2006 Apr 5;98(7):451-9 - PubMed
  25. Proc R Soc Med. 1965 May;58:295-300 - PubMed
  26. Diabetes Care. 2008 Apr;31(4):701-7 - PubMed
  27. J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):708-11 - PubMed
  28. Am J Clin Nutr. 2007 Jun;85(6):1586-91 - PubMed
  29. Anticancer Res. 1990 Sep-Oct;10(5A):1307-11 - PubMed
  30. Asian Pac J Cancer Prev. 2007 Apr-Jun;8(2):236-42 - PubMed
  31. Anticancer Res. 2008 May-Jun;28(3B):1955-63 - PubMed
  32. Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2303-9 - PubMed
  33. J Am Acad Dermatol. 2001 May;44(5):837-46 - PubMed
  34. Cancer Causes Control. 2008 Jun;19(5):527-35 - PubMed
  35. Lancet. 1985 Feb 9;1(8424):307-9 - PubMed
  36. Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):1042-51 - PubMed
  37. Int J Cancer. 1975 Apr 15;15(4):617-31 - PubMed
  38. Lung Cancer. 2002 Jan;35(1):43-51 - PubMed
  39. Sci Am. 1996 Jul;275(1):52-3, 56-9 - PubMed
  40. Int J Cancer. 2008 Apr 15;122(8):1690-4 - PubMed
  41. J Natl Cancer Inst. 2005 Feb 2;97(3):199-209 - PubMed
  42. J Bone Miner Res. 2007 Dec;22 Suppl 2:V86-90 - PubMed
  43. Ann Med. 1995 Oct;27(5):565-8 - PubMed
  44. Int J Cancer. 2006 Oct 1;119(7):1530-6 - PubMed
  45. Carcinogenesis. 2008 Jan;29(1):93-9 - PubMed
  46. Eur J Dermatol. 2007 Sep-Oct;17(5):428-34 - PubMed
  47. Br J Dermatol. 2002 Aug;147(2):197-213 - PubMed
  48. Cancer. 2002 Mar 15;94(6):1867-75 - PubMed
  49. Am J Clin Nutr. 2007 Mar;85(3):860-8 - PubMed
  50. Eur J Clin Nutr. 1999 Dec;53(12):920-6 - PubMed
  51. Anticancer Res. 2006 Jul-Aug;26(4A):2605-14 - PubMed
  52. Leuk Lymphoma. 1996 Oct;23(3-4):323-31 - PubMed
  53. J Natl Cancer Inst. 1996 Nov 6;88(21):1560-70 - PubMed
  54. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1283-6 - PubMed
  55. Breast Cancer Res Treat. 2007 May;102(3):323-8 - PubMed
  56. Int J Health Geogr. 2007 Jul 26;6:34 - PubMed
  57. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):59-64 - PubMed
  58. Lancet. 1982 Jan 9;1(8263):74-6 - PubMed
  59. Prev Med. 2007 Nov;45(5):327-31 - PubMed
  60. N Engl J Med. 2006 Feb 16;354(7):669-83 - PubMed
  61. Acta Pharmacol Sin. 2007 Sep;28(9):1373-82 - PubMed
  62. Cancer Res. 2006 Oct 15;66(20):10213-9 - PubMed
  63. Adv Exp Med Biol. 2008;624:43-54 - PubMed
  64. Jpn J Clin Oncol. 1985 Jun;15(2):403-13 - PubMed
  65. Rev Infect Dis. 1982 Nov-Dec;4(6):1270-4 - PubMed
  66. Prostate. 2007 Sep 1;67(12):1362-70 - PubMed
  67. J Natl Cancer Inst. 2008 Jun 4;100(11):796-804 - PubMed
  68. Epidemiol Infect. 2006 Dec;134(6):1129-40 - PubMed
  69. Ann Epidemiol. 2003 Jul;13(6):395-404 - PubMed
  70. BMC Cancer. 2006 Nov 10;6:264 - PubMed
  71. Carcinogenesis. 2005 Feb;26(2):429-40 - PubMed
  72. Eur J Cancer. 2007 Jul;43(11):1701-12 - PubMed
  73. Anticancer Res. 2008 Nov-Dec;28(6B):4003-8 - PubMed
  74. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1688-95 - PubMed
  75. Ann Neurol. 2007 Apr;61(4):288-99 - PubMed
  76. Int J Cancer. 2008 Jan 1;122(1):144-54 - PubMed
  77. J Clin Oncol. 2008 Dec 1;26(34):5596-602 - PubMed
  78. BMJ. 1996 May 4;312(7039):1128-31 - PubMed
  79. J Nutr. 2005 Oct;135(10):2350-4 - PubMed
  80. J Natl Cancer Inst. 1994 Jan 5;86(1):33-8 - PubMed
  81. Cancer. 2002 Jan 1;94(1):272-81 - PubMed
  82. Ann Epidemiol. 1993 Jan;3(1):103-10 - PubMed
  83. Cancer Causes Control. 1998 Aug;9(4):425-32 - PubMed
  84. Health Place. 1998 Dec;4(4):355-64 - PubMed
  85. Eur Urol. 2004 Mar;45(3):271-9 - PubMed
  86. Horm Metab Res. 2003 Nov-Dec;35(11-12):694-704 - PubMed
  87. Int J Epidemiol. 1980 Sep;9(3):227-31 - PubMed
  88. J Cell Biochem. 2003 Feb 1;88(2):363-71 - PubMed
  89. Cancer Causes Control. 2006 Oct;17(8):1091-101 - PubMed
  90. J Investig Dermatol Symp Proc. 1996 Apr;1(1):97-101 - PubMed
  91. Lancet. 1989 Nov 18;2(8673):1176-8 - PubMed
  92. Clin J Am Soc Nephrol. 2008 Sep;3(5):1535-41 - PubMed
  93. Urology. 2008 Mar;71(3):531-5 - PubMed
  94. Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1889-93 - PubMed
  95. Occup Environ Med. 2002 Apr;59(4):257-62 - PubMed
  96. Cancer. 2008 Nov 1;113(9):2398-407 - PubMed
  97. Nutr Cancer. 2004;48(2):115-23 - PubMed
  98. Lung Cancer. 2007 Mar;55(3):263-70 - PubMed
  99. Adv Exp Med Biol. 2008;624:104-16 - PubMed
  100. Curr Pharm Des. 2000 May;6(7):717-32 - PubMed
  101. ChemMedChem. 2006 Aug;1(8):783-802 - PubMed
  102. Health Phys. 2004 Nov;87(5):532-8 - PubMed
  103. Dis Markers. 2007;23(4):247-59 - PubMed
  104. J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):668-74 - PubMed
  105. Epidemiol Infect. 2008 Jan;136(1):1-9 - PubMed
  106. Anticancer Res. 2009 Sep;29(9):3537-45 - PubMed
  107. J Epidemiol Community Health. 2008 Jan;62(1):69-74 - PubMed
  108. Ann Epidemiol. 2007 Dec;17(12):956-63 - PubMed
  109. J Clin Oncol. 2007 Feb 10;25(5):479-85 - PubMed
  110. Recent Results Cancer Res. 2003;164:99-110 - PubMed
  111. Curr Med Res Opin. 2008 Jan;24(1):139-49 - PubMed
  112. Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2467-72 - PubMed
  113. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3274-8 - PubMed
  114. J Natl Med Assoc. 2006 Mar;98(3):357-64 - PubMed
  115. Photochem Photobiol. 1999 Aug;70(2):243-7 - PubMed
  116. Lancet. 1981 Nov 28;2(8257):1185-90 - PubMed
  117. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1721S-4S - PubMed
  118. Br J Cancer. 2007 Jul 2;97(1):123-8 - PubMed
  119. Eur J Surg Oncol. 2008 Jul;34(7):765-70 - PubMed
  120. Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):668-73 - PubMed
  121. Br J Cancer. 2005 Sep 5;93(5):571-4 - PubMed

Publication Types